Can a serum bring back fuller brows? a trial investigates
NCT ID NCT07775989
First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time
Summary
This trial tests whether a cosmetic eyebrow serum called Dallixa can improve eyebrow fullness in adults with naturally sparse eyebrows (hypotrichosis). Participants will use the serum and be assessed over five months for changes in eyebrow growth, thickness, and density. The study aims to see if the product is both effective and safe for everyday use.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a dermo cosmetic eyebrow serum containing herbal or vitamin ingredients
- What this could lead to
- If effective, this serum could offer a non-invasive way to improve eyebrow fullness in people with naturally sparse eyebrows.
- What could go wrong
- This is a small, single-arm trial with no placebo group, so results may not be conclusive. As a cosmetic product, effects may be modest and vary between individuals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
49 people
The number who actually took part.
- Started
-
Aug 2025
- Finished
-
Apr 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Individuals of any sex and at least 18 years of age 2. Subjects who have inadequate eyebrow due to natural causes (eyebrow hypotrichosis) 3. A Grade 1 or 2 on the Global Eyebrow Assessment (GEBA) scale 4. Subjects who agree to forgo any additional treatment to the brows, such as waxing, plucking, threading and/or tinting, laser hair removal, and/or bleaching for the duration of the study. 5. Willing to complete all required study visits, procedures, and evaluations including photography. Exclusion Criteria: 1. Subjects with any uncontrolled systemic disease (like systemic diseases which could prevent hair growth or produce abnormal growth) 2. known diagnoses possibly underlying or contributing to the state of the eyebrows including, but not limited to, telogen effluvium or anagen effluvium 3. Any known diseases, infection or abnormalities to the eyelid or eyebrow (including eczema, seborrheic dermatitis, alopecia areata, trichotillomania, thyroid diseases, atopic dermatitis, history of trauma or burn to the eyebrow region and etc.) 4. Subjects that have thinning brows as a result of over plucking, trichotillomania, chemotherapy or any other condition or treatment that causes hair loss. 5. Patients with permanent eyebrow loss due to over-grooming 6. Allergy to any component of the investigational product 7. Subjects with temporary or semipermanent eyebrow fillers, any permanent or semi-permanent tint, dye or bleaching within 3 months 8. Any skin pigmentation/depigmentation, microblading, tattoos, permanent eye and/or eyebrow make-up, moles, scars, or other characteristics within the eyebrow area 9. Subjects who used permanent injectable fillers in and around the eyebrow area within 12 months 10. Use of any over-the-counter or prescription eyebrow growth product within 3 months 11. Subjects who had undergone any facial surgery (e.g., brow lift) or eyebrow extension within 3 months of screening 12. Current enrollment in an investigational product or device or participation in such a study within 30 days 13. Aphakic subjects and/or pseudophakic subjects with a torn posterior lens capsule 14. Subjects with known risk factors for macular edema 15. Patients with a history of glaucoma and/or increased ocular pressure 16. Patients who are currently using an IOP-lowering prostaglandin analog 17. Previous cosmetic surgery to the upper face (e.g., periorbital surgery, brow lift, eyelid or eyebrow surgery, etc.). 18. Any planned facial cosmetic procedure that would interfere with the evaluation of the eyebrows 19. Participation in another investigational product or device study within the last 30 days 20. Females who are pregnant, nursing, or planning a pregnancy during the study, or who are of childbearing potential and not using a reliable method of contraception
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hypotrichosis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Akdeniz Üniversitesi Hastanesi
Antalya, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.